Literature DB >> 3988933

Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome.

I Bernardini, W B Rizzo, M Dalakas, J Bernar, W A Gahl.   

Abstract

Plasma and urine free and acyl carnitine were measured in 19 children with nephropathic cystinosis and renal Fanconi syndrome. Each patient exhibited a deficiency of plasma free carnitine (mean 11.7 +/- 4.0 [SD] nmol/ml) compared with normal control values (42.0 +/- 9.0 nmol/ml) (P less than 0.001). Mean plasma acyl carnitine in the cystinotic subjects was normal. Four subjects with Fanconi syndrome but not cystinosis displayed the same abnormal pattern of plasma carnitine levels; controls with acidosis or a lysosomal storage disorder (Fabry disease), but not Fanconi syndrome, had entirely normal plasma carnitine levels. Two postrenal transplant subjects with cystinosis but without Fanconi syndrome also had normal plasma carnitine levels. Absolute amounts of urinary free carnitine were elevated in cystinotic individuals with Fanconi syndrome. In all 21 subjects with several different etiologies for the Fanconi syndrome, the mean fractional excretion of free carnitine (33%) as well as acyl carnitine (26%) greatly exceeded normal values (3 and 5%, respectively). Total free carnitine excretion in Fanconi syndrome patients correlated with total amino acid excretion (r = 0.76). Two cystinotic patients fasted for 24 h and one idiopathic Fanconi syndrome patient fasted for 5 h showed normal increases in plasma beta-hydroxybutyrate and acetoacetate, which suggested that hepatic fatty acid oxidation was intact despite very low plasma free carnitine levels. Muscle biopsies from two cystinotic subjects with Fanconi syndrome and plasma carnitine deficiency had 8.5 and 13.1 nmol free carnitine per milligram of noncollagen protein, respectively (normal controls, 22.3 and 17.1); total carnitines were 11.8 and 13.3 nmol/mg noncollagen protein (controls 33.5, 20.0). One biopsy revealed a mild increase in lipid droplets. The other showed mild myopathic features with variation in muscle fiber size, small vacuoles, and an increase in lipid droplets. In renal Fanconi syndrome, failure to reabsorb free and acyl carnitine results in a secondary plasma and muscle free carnitine deficiency.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3988933      PMCID: PMC425435          DOI: 10.1172/JCI111806

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  5-oxoprolinuria: biochemical observations and case report.

Authors:  S P Spielberg; L I Kramer; S I Goodman; J Butler; F Tietze; P Quinn; J D Schulman
Journal:  J Pediatr       Date:  1977-08       Impact factor: 4.406

2.  An improved and simplified radioisotopic assay for the determination of free and esterified carnitine.

Authors:  J D McGarry; D W Foster
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

3.  Hyperinsulinism in infancy: diagnosis by demonstration of abnormal response to fasting hypoglycemia.

Authors:  C A Stanley; L Baker
Journal:  Pediatrics       Date:  1976-05       Impact factor: 7.124

4.  Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo.

Authors:  J G Thoene; R G Oshima; J C Crawhall; D L Olson; J A Schneider
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

5.  An enzymatic fluorimetric micromethod for the determination of acetoacetate, -hydroxybutyrate, pyruvate and lactate.

Authors:  C Olsen
Journal:  Clin Chim Acta       Date:  1971-07       Impact factor: 3.786

6.  Concentration of carnitine in human muscle tissue.

Authors:  G Cederblad; S Lindstedt; K Lundholm
Journal:  Clin Chim Acta       Date:  1974-06-28       Impact factor: 3.786

7.  Excretion of L-carnitine in man.

Authors:  G Cederblad; S Lindstedt
Journal:  Clin Chim Acta       Date:  1971-06       Impact factor: 3.786

8.  The effect of ketone bodies on the determination of creatinine.

Authors:  P J Watkins
Journal:  Clin Chim Acta       Date:  1967-11       Impact factor: 3.786

9.  Selective and nonselective susceptibility of muscle fiber types. A new approach to human neuromuscular diseases.

Authors:  W K Engel
Journal:  Arch Neurol       Date:  1970-02

10.  Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome.

Authors:  A G Engel; C Angelini
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

View more
  21 in total

Review 1.  The use of levo-carnitine in children with renal disease: a review and a call for future studies.

Authors:  Brook Belay; Nora Esteban-Cruciani; Christine A Walsh; Frederick J Kaskel
Journal:  Pediatr Nephrol       Date:  2005-12-23       Impact factor: 3.714

Review 2.  Laboratory approach to mitochondrial diseases.

Authors:  D Parra; A González; C Mugueta; A Martínez; I Monreal
Journal:  J Physiol Biochem       Date:  2001-09       Impact factor: 4.158

Review 3.  L-Carnitine.

Authors:  J H Walter
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

Review 4.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

5.  Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiency.

Authors:  W A Gahl; I Bernardini; J D Finkelstein; A Tangerman; J J Martin; H J Blom; K D Mullen; S H Mudd
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

6.  Lipoprotein lipase, hepatic lipase, and carnitine in premature infants.

Authors:  L M Rovamo; E A Nikkilä; K O Raivio
Journal:  Arch Dis Child       Date:  1988-02       Impact factor: 3.791

Review 7.  Nephropathic cystinosis: late complications of a multisystemic disease.

Authors:  Galina Nesterova; William Gahl
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

8.  Role of carnitine in cancer chemotherapy-induced multiple organ toxicity.

Authors:  Mohamed M Sayed-Ahmed
Journal:  Saudi Pharm J       Date:  2010-08-05       Impact factor: 4.330

9.  Hepatic methionine adenosyltransferase deficiency in a 31-year-old man.

Authors:  W A Gahl; J D Finkelstein; K D Mullen; I Bernardini; J J Martin; P Backlund; K G Ishak; J H Hoofnagle; S H Mudd
Journal:  Am J Hum Genet       Date:  1987-01       Impact factor: 11.025

10.  Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome.

Authors:  W A Gahl; I Bernardini; M Dalakas; W B Rizzo; G S Harper; J M Hoeg; O Hurko; J Bernar
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.